International Healthway Corporation: Complete Company History, Business Model and Latest Developments

SixSpace6 days agoLast Updated: November 4, 2026

12 9 minutes read

International Healthway Corporation is the former name of a Singapore-based healthcare investment and services company that developed into what is now known as OUE Healthcare Limited. Its history is important for understanding its corporate identity, healthcare investments, international expansion and position in the Asian healthcare industry. The company has evolved through ownership changes, corporate rebranding and investments in hospitals, medical centres, specialist practices and healthcare-related businesses. This article explores its origins, business activities, company name changes, international presence, strategic partnerships and latest corporate developments.

Table of Contents

What Is International Healthway Corporation?

International Healthway Corporation Limited was a Singapore-incorporated healthcare company established as a platform for investing in and developing healthcare-related businesses. It became publicly listed on the Singapore Exchange’s Catalist board in 2013 under the stock code 5WA. Its activities were associated with healthcare delivery, medical facilities, hospitals, nursing homes and healthcare property investments. The business later became part of the OUE group, leading to a significant change in its ownership structure and corporate identity. Today, the name International Healthway Corporation is primarily relevant when researching the company’s historical records, earlier announcements and corporate development. Its successor, OUE Healthcare Limited, continues to operate as a healthcare investment group with interests across several Asian markets.

History and Background of International Healthway Corporation

The company’s history began in Singapore, where it was incorporated on 18 February 2013. It entered the public market in July of the same year through a listing on the Singapore Exchange Catalist board. Its original business direction focused on opportunities in the healthcare sector, particularly the growing demand for medical services and healthcare infrastructure across Asia. Rather than operating solely as a traditional medical provider, the company pursued a broader investment approach involving healthcare facilities, operating businesses and strategic partnerships. This structure allowed it to participate in different parts of the healthcare industry while developing relationships with medical operators and institutional partners. Its subsequent association with OUE marked a major turning point, transforming the business into a component of a larger corporate group’s regional healthcare strategy.

Corporate Name Changes and Ownership Transformation

International Healthway Corporation underwent significant changes in its corporate identity as its ownership and strategic direction evolved. On 9 October 2017, shareholders approved the change from International Healthway Corporation Limited to OUE Lippo Healthcare Limited. The stated rationale was to reflect the company’s relationship with OUE Limited and the Lippo group. In 2023, the company proposed another name change, this time to OUE Healthcare Limited, explaining that the new name would provide a clearer connection to its immediate controlling shareholder, OUE Limited. The change was subsequently implemented. These developments are important because the three names refer to successive identities of the same corporate business rather than three unrelated healthcare companies. Researchers looking for historical financial statements or stock announcements should therefore consider all three names when investigating its corporate history.

Main Business Model and Healthcare Operations

The business model of OUE Healthcare is based on owning, operating and investing in healthcare-related assets and service providers. This approach combines direct participation in healthcare delivery with strategic investments and partnerships that support the wider medical industry. Its portfolio covers hospitals, specialist medical practices, primary care services, rehabilitation facilities and healthcare-related investments. The company also has exposure to healthcare real estate and investment structures, including First REIT, which provides an additional connection to the ownership and management of healthcare properties. This diversified structure allows the group to participate in several areas of the healthcare market rather than depending entirely on one hospital or medical service. Its strategy is particularly relevant in Asian markets where demand for accessible medical services, specialist treatment and modern healthcare infrastructure continues to create opportunities.

International Presence and Major Healthcare Markets

OUE Healthcare has developed a regional presence through investments and operating partnerships in different Asian countries. Singapore remains an important part of its healthcare strategy, while China and Myanmar provide additional opportunities for hospital development and medical services. Its historical portfolio has also included healthcare-related assets in Japan and Indonesia, although individual investments and ownership arrangements have changed over time. This international approach allows the company to participate in markets with different healthcare systems, patient requirements and investment conditions. However, operating across multiple countries also requires the group to manage different regulations, licensing requirements, local partnerships and financial risks. Its international presence should therefore be understood as a combination of direct operations, joint ventures, strategic investments and healthcare-related assets rather than a single network of wholly owned hospitals.

Healthcare Activities in Singapore

Singapore plays an important role in the group’s strategy because of its established medical infrastructure, healthcare standards and specialist services. Through its strategic investment in Healthway Medical Corporation, OUE Healthcare has exposure to a substantial private healthcare network offering family medicine, specialist consultations, dental services, executive health screening and day surgery. Another important part of its Singapore platform is O2 Healthcare Group, which brings together specialist practices in respiratory medicine and cardiothoracic surgery. The group has also expanded into rehabilitation through its investment in Rehab Matters, a provider focused on physiotherapy, medically directed fitness and cardiopulmonary rehabilitation. These activities support a broader healthcare model that includes prevention, diagnosis, specialist treatment and recovery. Rather than concentrating only on hospital ownership, the strategy connects different stages of patient care through a portfolio of healthcare providers.

Hospital Investments in China

China has been an important market in the company’s regional expansion, particularly through partnerships with China Merchants Group and other healthcare institutions. Its development activities have included Changshu China Merchants-Lippo Obstetrics and Gynaecology Hospital in Jiangsu and Shenzhen China Merchants-Lippo Prince Bay Hospital. The company also developed relationships with medical institutions to strengthen specialist services and hospital operations. According to its published corporate milestones, Changshu Hospital opened in 2023, while the Prince Bay Hospital project progressed through development and licensing before commencing operations in 2025. These projects demonstrate how the group uses joint ventures and local partnerships to enter the Chinese healthcare market. Such arrangements can provide access to local expertise and infrastructure, although their success depends on operational execution, regulatory compliance, patient demand and the ability to establish sustainable hospital services.

Healthcare Investments in Myanmar

Myanmar represents another part of the group’s international healthcare portfolio. Its involvement in the market developed through a joint venture with First Myanmar Investment Public Company Limited, involving the ownership, operation and management of Pun Hlaing Hospitals. This investment provided exposure to private hospital services in a developing healthcare market. The group’s historical activities in Myanmar also demonstrate the importance of partnerships when expanding into countries with different economic and regulatory environments. However, political conditions, economic uncertainty, currency fluctuations and healthcare infrastructure challenges can influence the performance of businesses operating in the country. These factors make it important to distinguish between a company’s stated regional presence and the actual financial or operational performance of individual facilities.

Strategic Partnerships and Corporate Investments

Strategic partnerships have played a central role in the development of International Healthway Corporation and its successor. One significant relationship was established with China Merchants Group, supporting the development and management of healthcare facilities in China. The company also formed a relationship with ITOCHU Corporation, which became a strategic shareholder in 2018. Another important investment involved First REIT and its management company, giving the group a connection to healthcare-focused real estate investment. Over time, its partnerships expanded to include medical institutions and specialist healthcare providers. In 2024, the group entered healthcare alliance agreements with Shanghai Changzheng Hospital and Zhongda Hospital of Southeast University. These relationships illustrate a business strategy that relies on combining investment capital, medical expertise, local market knowledge and operating partnerships. However, partnerships do not automatically guarantee commercial success, and their results depend on the responsibilities, financial commitments and performance of each participating organisation.

Latest Developments and Corporate Privatisation in 2026

One of the most important recent developments concerns the proposed acquisition and privatisation of OUE Healthcare Limited by Treasure International Holdings Pte. Ltd. On 24 August 2026, the offeror announced a proposal to acquire the remaining issued ordinary shares at S$0.050 per share through a scheme of arrangement. The company’s shareholders subsequently voted on the proposal at a scheme meeting held on 2 November 2026. The company announced that the scheme had been approved, with 61.90% of participating shareholders voting in favour by number and 89.40% of the represented shares voting in favour by value. However, shareholder approval did not mean that the acquisition and delisting had already been completed. The company stated that it would apply to the Singapore court for approval of the scheme and would also seek the necessary SGX approval for delisting. Its announcement provided an indicative timeline, including an expected court hearing around 30 November 2026 and a proposed effective date around 10 December 2026, subject to the required conditions. As of 4 November 2026, these were future proposed milestones rather than completed events.

Financial Performance and Business Position

Understanding the company’s financial position requires looking at its annual reports and distinguishing between OUE Healthcare’s standalone performance and the wider OUE group’s consolidated figures. The 2025 annual reporting materials describe a portfolio that includes Singapore specialist healthcare businesses, investments in Healthway Medical Corporation, Chinese hospital operations and healthcare interests in Myanmar. They also show that the healthcare segment remains one component of the wider OUE business. In OUE Limited’s 2025 annual report, the healthcare segment recorded turnover of approximately S$152.7 million, compared with approximately S$152.2 million in 2024. These figures relate to the healthcare segment presented in OUE Limited’s consolidated reporting and should not automatically be interpreted as the standalone revenue of the former International Healthway Corporation. Investors and researchers should also examine operating cash flow, borrowings, investment valuations, joint venture contributions and non-cash accounting adjustments when assessing financial health. A single revenue figure cannot establish whether a healthcare business is profitable, financially stable or capable of funding future expansion.

Opportunities and Challenges in the Asian Healthcare Industry

The company’s regional strategy reflects several long-term opportunities in Asian healthcare, including demand for specialist medical treatment, preventive health services, rehabilitation and modern hospital facilities. Growing urban populations and changing healthcare expectations can create opportunities for established medical operators and investors with the resources to develop quality facilities. Partnerships with recognised medical institutions can also support clinical expertise and improve access to specialist services. Nevertheless, healthcare investment carries substantial challenges. Hospitals require significant capital expenditure, qualified medical professionals, appropriate licences, reliable equipment and strong operational management. Healthcare businesses must also comply with local medical regulations, patient safety standards, data protection requirements and employment laws. International operators face additional exposure to exchange-rate movements, political developments, local economic conditions and differences in healthcare reimbursement systems. These factors mean that expansion into new markets requires careful financial planning and long-term operational commitment. The company’s diversified portfolio offers exposure to multiple healthcare activities, but diversification alone does not remove the risks associated with individual markets or investments.

How to Research International Healthway Corporation’s Corporate Records

Anyone researching International Healthway Corporation should understand that historical documents may appear under different company names. Earlier announcements, shareholder circulars and financial statements may use International Healthway Corporation Limited, while later documents may refer to OUE Lippo Healthcare Limited or OUE Healthcare Limited. The company’s Singapore registration number, 201304341E, is a useful identifier when matching historical and current corporate records. Its former SGX stock code, 5WA, is also useful when searching for historical share announcements and financial information. For a reliable investigation, company annual reports, official investor announcements and Singapore Exchange disclosures should take priority over third-party business directories or outdated stock profiles. This is particularly important when checking ownership, directors, financial performance, corporate transactions and the status of the proposed privatisation. Historical company information should always be matched against the relevant reporting date because ownership arrangements and business activities can change.

Conclusion

International Healthway Corporation has undergone a significant transformation from its original identity as a Singapore-listed healthcare investment company to its successor, OUE Healthcare Limited. Its development reflects a broader strategy of building a regional healthcare portfolio through hospitals, specialist medical services, strategic investments and international partnerships. Singapore, China and Myanmar have been important parts of this journey, while investments in healthcare-related businesses have helped diversify its activities. The proposed 2026 privatisation is another major corporate milestone, although court approval and other required conditions remained outstanding as of 4 November 2026. Understanding the company’s history therefore requires examining both its original identity and its subsequent corporate development. Its story provides a useful example of how healthcare investment companies can evolve through changes in ownership, partnerships and regional business strategies.

Also read: Businesses Near Me: A Practical Guide to Finding Trusted Local Services

FAQs

1. What was International Healthway Corporation?

International Healthway Corporation was a Singapore-based healthcare investment company incorporated in 2013 and later renamed OUE Lippo Healthcare before becoming OUE Healthcare Limited.

2. Is International Healthway Corporation still operating under its original name?

No. The company changed its name twice, becoming OUE Lippo Healthcare Limited in 2017 and OUE Healthcare Limited in 2023.

3. Where was International Healthway Corporation headquartered?

International Healthway Corporation was incorporated in Singapore, and its successor, OUE Healthcare Limited, remains a Singapore-registered company.

4. What industry was International Healthway Corporation involved in?

The company operated in the healthcare investment sector, with interests in hospitals, medical clinics, specialist practices, nursing homes and healthcare-related properties.

5. What is the relationship between International Healthway Corporation and OUE Healthcare?

OUE Healthcare is the successor under the same corporate registration, following the company’s rebranding and ownership transformation after its acquisition by OUE.